Anne Juchet-Daub

Anne Daub is a Partner on the Therapeutics team at Deerfield Management in New York, where she joined in 2024. In her current role, she is responsible for leading investments and strategy related to therapeutics, focusing particularly on drug development and biotechnology innovation within Deerfield’s diversified healthcare investment portfolio.

Throughout her career, Anne has specialized in the biotechnology sector, previously serving as Vice President and Biotechnology Senior Analyst at T. Rowe Price and as a Senior Analyst at Citadel LLC and Soros Fund Management, along with earlier analytical roles at Visium Asset Management, Bear Stearns & Co., Integrated Finance Ltd., and J.P. Morgan Securities Inc.. Her expertise centers on equity research and investment analysis for biotechnology and pharmaceutical companies.

Anne holds a graduate degree in Finance from HEC Paris, a top French business school, which supports her rigorous approach to investment and analytical work. She is recognized for her deep sector knowledge and has contributed to advancing investment methodologies in biotechnology, therapeutics, and life sciences throughout her distinguished career.